Retagliptin Phosphate
CAS: 1256756-88-3
Ref. 3D-GAC75688
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Información del producto
Retagliptin is a dipeptidyl peptidase-4 inhibitor that is used to treat type 2 diabetes. It inhibits the action of dipeptidyl peptidase-4 (DPP-4) in the pancreas and blocks the breakdown of incretin hormones, such as glucagon-like peptide 1 (GLP-1). Retagliptin has a dose-dependent pharmacokinetic profile and is metabolized by both liver and intestinal enzymes. It also undergoes renal elimination, with about 40 percent excreted unchanged in urine. The most common side effects include low blood pressure, diarrhea, nausea, dizziness, headache, and vomiting. Retagliptin has been shown to have toxicokinetics parameters similar to those of animals.
Propiedades químicas
Consulta técnica sobre: 3D-GAC75688 Retagliptin Phosphate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
